|
Name |
(1R,2S,4aR,6S,8R,8aS)-1-(3-hydroxypropanoyl)-1,3,6,8-tetramethyl-4a,5,6,7,8,8a-hexahydro-2H-naphthalene-2-carboxylic acid
|
Molecular Formula | C18H28O4 | |
IUPAC Name* |
(1R,2S,4aR,6S,8R,8aS)-1-(3-hydroxypropanoyl)-1,3,6,8-tetramethyl-4a,5,6,7,8,8a-hexahydro-2H-naphthalene-2-carboxylic acid
|
|
SMILES |
C[C@H]1C[C@H]([C@H]2[C@H](C1)C=C([C@@H]([C@]2(C)C(=O)CCO)C(=O)O)C)C
|
|
InChI |
InChI=1S/C18H28O4/c1-10-7-11(2)15-13(8-10)9-12(3)16(17(21)22)18(15,4)14(20)5-6-19/h9-11,13,15-16,19H,5-8H2,1-4H3,(H,21,22)/t10-,11+,13+,15-,16+,18+/m0/s1
|
|
InChIKey |
SFTQDPVLDKOILY-IBHGEBJCSA-N
|
|
Synonyms |
diplodiatoxin
|
|
CAS | NA | |
PubChem CID | 100621776 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 308.4 | ALogp: | 2.3 |
HBD: | 2 | HBA: | 4 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 74.6 | Aromatic Rings: | 2 |
Heavy Atoms: | 22 | QED Weighted: | 0.777 |
Caco-2 Permeability: | -5.178 | MDCK Permeability: | 0.00000801 |
Pgp-inhibitor: | 0.729 | Pgp-substrate: | 0.643 |
Human Intestinal Absorption (HIA): | 0.179 | 20% Bioavailability (F20%): | 0.19 |
30% Bioavailability (F30%): | 0.022 |
Blood-Brain-Barrier Penetration (BBB): | 0.816 | Plasma Protein Binding (PPB): | 76.25% |
Volume Distribution (VD): | 0.384 | Fu: | 20.97% |
CYP1A2-inhibitor: | 0.041 | CYP1A2-substrate: | 0.306 |
CYP2C19-inhibitor: | 0.027 | CYP2C19-substrate: | 0.774 |
CYP2C9-inhibitor: | 0.261 | CYP2C9-substrate: | 0.839 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.143 |
CYP3A4-inhibitor: | 0.069 | CYP3A4-substrate: | 0.267 |
Clearance (CL): | 7.25 | Half-life (T1/2): | 0.938 |
hERG Blockers: | 0.031 | Human Hepatotoxicity (H-HT): | 0.41 |
Drug-inuced Liver Injury (DILI): | 0.955 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.035 | Maximum Recommended Daily Dose: | 0.019 |
Skin Sensitization: | 0.256 | Carcinogencity: | 0.11 |
Eye Corrosion: | 0.274 | Eye Irritation: | 0.846 |
Respiratory Toxicity: | 0.522 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003781 | 0.397 | D0E9KA | 0.261 | ||||
ENC003292 | 0.373 | D03IKT | 0.255 | ||||
ENC001954 | 0.363 | D08PIQ | 0.248 | ||||
ENC003792 | 0.358 | D0D4JO | 0.243 | ||||
ENC003775 | 0.346 | D00GOS | 0.243 | ||||
ENC003818 | 0.324 | D0F1EX | 0.243 | ||||
ENC003817 | 0.324 | D03SXE | 0.240 | ||||
ENC004696 | 0.321 | D00XPC | 0.237 | ||||
ENC005218 | 0.321 | D0D2TN | 0.236 | ||||
ENC005182 | 0.320 | D0CZ1Q | 0.236 |